Recurrent Chronic Lymphoid Leukemia
1 clinical trials · Condition
◉ Watch Recurrent Chronic Lymphoid Leukemia
| Record | Firm | Date |
|---|---|---|
| ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL (NCT02787369) | Dana-Farber Cancer Institute | 2016-05-01 |
Track Recurrent Chronic Lymphoid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.